GNW-Adhoc: US FDA approves Idorsia's once-daily TRYVIO (aprocitentan) ...
GNW-Adhoc: Idorsia and Viatris enter into a significant ...
GNW-Adhoc: Idorsia presents at the J.P. Morgan Healthcare ...